COMMUNIQUÉS West-GlobeNewswire

Merit Medical to Participate at Six Conferences
22/02/2018
BTIG – March 1 Raymond James – March 7 Barclays – March 15 Oppenheimer – March 21 Needham – March 28 Sidoti – March 29 SOUTH JORDAN, Utah, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI ), a [...]
Midland, TX Hand Surgeon Launches Custom Specialty Website with Responsive Design
22/02/2018
MIDLAND, Texas, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Injuries and conditions of the hand and wrist often require the advanced skill of a plastic surgeon who has undergone extensive education in the delicate art of hand [...]
Mount Tam Biotechnologies Announces that the European Patent Office Has Allowed a Key Patent for Lead Compound TAM-01
22/02/2018
NOVATO, CA , Feb. 22, 2018 (GLOBE NEWSWIRE) -- Mount Tam Biotechnologies, Inc. ("Mount Tam") (OTC PINK: MNTM), a company focused on the discovery and development of novel mTOR inhibitors, is pleased to announce the [...]
Radient Technologies Inc. Named to the 2018 TSX Venture 50 List of Companies
22/02/2018
EDMONTON, Alberta, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX-V: RTI ), a world leader in industrial-scale natural ingredient extraction, purification and formulation [...]
Tower One to Spin Out USA-Based TCTS
22/02/2018
VANCOUVER, British Columbia, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTCQB:TOWTF) (Frankfurt: 1P3N ) (the “Company ” or “ Tower One ”) is pleased to announce that it intends to spin-out its [...]
Tetra Bio-Pharma Announces Filing of Restated Financial Statements and MD&A
22/02/2018
OTTAWA, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“ Tetra ” or the “ Corporation ”) (TSX-V: TBP ) (OTCQB:TBPMF), announced today it has filed restated Condensed Consolidated interim financial statements ( [...]
Verona Pharma to Announce Operational Update and Financial Results for Full Year ended December 31, 2017
22/02/2018
LONDON, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Apellis Pharmaceuticals Announces 18-Month Results of Phase 2 Study (FILLY) of APL-2 in Geographic Atrophy
22/02/2018
CRESTWOOD, Ky. and CAMBRIDGE, Mass., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS ), a clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for [...]
Key Measure of Precipio’s Pathology Sales Growth 4X Prior Quarter
22/02/2018
NEW HAVEN, Conn., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO ), announced today that within the first half of Q1-2018 it has set up trials for pathology lab services with 4 times as many new oncology [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
22/02/2018
FIT Biotech Oy Company release February 22, 2018 at 3:00 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]
Vericel to Report Fourth-Quarter and Full-Year 2017 Financial Results on March 5, 2018
22/02/2018
CAMBRIDGE, Mass., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the following webcast [...]
The Joint Corp. to Host Conference Call on Thursday, March 8, to Discuss Fourth Quarter and Full Year 2017 Results
22/02/2018
SCOTTSDALE, Ariz., Feb. 22, 2018 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT ), a national operator, manager and franchisor of chiropractic clinics, announced it will report its fourth quarter and full year 2017 [...]
ContraVir Pharmaceuticals Announces TXL™ Has Been Granted Orphan Drug Designation for the Treatment of HBV in a Pediatric Population
22/02/2018
EDISON, N.J., Feb. 22, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced [...]
Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call and Webcast
22/02/2018
NEW YORK, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ) a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
BioSig Technologies to Partner with Focus Marketing
22/02/2018
Santa Monica, CA, Feb. 22, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
Chimerix to Announce Fourth Quarter and Full Year 2017 Financial Results on March 1, 2018
22/02/2018
DURHAM, N.C., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq: CMRX ), a biopharmaceutical company developing novel antivirals for the growing population of immunocompromised patients, today announced that it [...]
Aegis Awarded Patent for Fast Acting Nasal Spray Opioid Blockers and Pain Medications
22/02/2018
SAN DIEGO, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 9,895,444 providing non-invasive metered nasal spray delivery of multiple opioid blockers such [...]
Hemostemix Signs Manufacturing Agreement with Aspire Health Science
22/02/2018
CALGARY, Alberta, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE:HEM) is pleased to announce it has finalized the terms of a contract manufacturing services agreement [...]
Emerald Health Therapeutics Named as #1 2018 TSX Venture 50™ Performer
22/02/2018
VICTORIA, British Columbia, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSX-V: EMH ) (OTCQX:EMHTF) ("Emerald") has achieved the #1 ranking in the 2018 TSX Venture 50™ for the clean technology [...]

Pages